does novo nordisk have a patent on semaglutide expiry opens door to cheaper weight-loss drugs in India Natco beats rivals with Rs

Many ladies combine this with modifications to diet, rest, and exercise for optimal impact

Before starting GLP-1 antagonists, talk to your healthcare provider to make sure theyre safe and appropriate for you

But beyond helping people feel full, it may also influence how the body responds to food and manages energy

The Indian government plans to offer incentives to promote local manufacturing of GLP-1 drugs by 2026, which will impact pricing and availability. Brazil In Brazil, the first generics of semaglutide (Ozempic) will launch in March 2026 after Novo Nordisks patent expires

"It is not against (World Anti-Doping Agency) rules to take L-carnitine as a supplement within the right quantities